Cazanat Cabozantinib 20mg tablets

Bottle of 20 mg Capsule

4.5 (154)

28,000

Cazanat Cabozantinib 20mg Tablet is a tyrosine kinase inhibitor used to treat progressive, metastatic medullary thyroid cancer, advanced renal cell carcinoma, and hepatocellular carcinoma in patients previously treated with sorafenib. It works by blocking multiple receptor tyrosine kinases—including VEGFR-1, -2, -3, KIT, TRKB, FLT-3, AXL, RET, MET, and TIE-2—that are involved in tumor growth and blood supply, helping slow or stop cancer progression.

Description

Introduction of Cazanat Cabozantinib 20mg Tablet:

Cazanat Cabozantinib 20mg Tablet is a tyrosine kinase inhibitor used to treat advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and medullary thyroid cancer.

This Tablet is taken by mouth, exactly as prescribed by your doctor. Your doctor will determine the appropriate dose and duration based on your specific condition, and this may change over time depending on your response to treatment. It’s important to take it exactly as advised — using it incorrectly or in excess can cause serious side effects. It may take several weeks or months for you to see or feel the benefits, so do not stop taking it unless your doctor tells you to.

Uses of Cazanat Cabozantinib 20mg Tablet:

Cazanat 20mg Tablet is indicated for the treatment of progressive, metastatic medullary thyroid cancer. It is also indicated for advanced renal cell carcinoma, and for hepatocellular carcinoma in patients previously treated with sorafenib.

Benefits of Cazanat Cabozantinib 20mg Tablet:

This tablet helps slow or stop the progression of aggressive cancers by cutting off the signals tumors rely on for growth and blood supply. It is particularly valuable for patients whose cancer has spread (metastasized) or who have already tried other treatments without success, such as sorafenib in hepatocellular carcinoma. It is a powerful and potentially toxic medication, so it’s important to discuss the risks and benefits with your doctor before starting treatment.

Mechanism of action of Cazanat Cabozantinib 20mg Tablet:

Cazanat Cabozantinib 20mg Tablet works by inhibiting multiple receptor tyrosine kinases, including VEGFR-1, -2, and -3, KIT, TRKB, FLT-3, AXL, RET, MET, and TIE-2. These receptors are involved in tumor growth and the formation of new blood vessels that supply tumors, so blocking them helps slow or stop cancer progression. For more clinical details, refer to MedlinePlus Drug Information, a trusted resource from the U.S. National Library of Medicine.

Contact Us

Info Table
Packaging Size 30 tablets
Brand Cazanat 20mg tablets
Composition Cabozantinib 20mg
Manufacturer Natco
Treatment to treat advanced renal cell carcinoma
Prescription/Non prescription Prescription
Vendor Info
Benefits
Reviews

Description

Introduction of Cazanat Cabozantinib 20mg Tablet:

Cazanat Cabozantinib 20mg Tablet is a tyrosine kinase inhibitor used to treat advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and medullary thyroid cancer.

This Tablet is taken by mouth, exactly as prescribed by your doctor. Your doctor will determine the appropriate dose and duration based on your specific condition, and this may change over time depending on your response to treatment. It’s important to take it exactly as advised — using it incorrectly or in excess can cause serious side effects. It may take several weeks or months for you to see or feel the benefits, so do not stop taking it unless your doctor tells you to.

Uses of Cazanat Cabozantinib 20mg Tablet:

Cazanat 20mg Tablet is indicated for the treatment of progressive, metastatic medullary thyroid cancer. It is also indicated for advanced renal cell carcinoma, and for hepatocellular carcinoma in patients previously treated with sorafenib.

Benefits of Cazanat Cabozantinib 20mg Tablet:

This tablet helps slow or stop the progression of aggressive cancers by cutting off the signals tumors rely on for growth and blood supply. It is particularly valuable for patients whose cancer has spread (metastasized) or who have already tried other treatments without success, such as sorafenib in hepatocellular carcinoma. It is a powerful and potentially toxic medication, so it’s important to discuss the risks and benefits with your doctor before starting treatment.

Mechanism of action of Cazanat Cabozantinib 20mg Tablet:

Cazanat Cabozantinib 20mg Tablet works by inhibiting multiple receptor tyrosine kinases, including VEGFR-1, -2, and -3, KIT, TRKB, FLT-3, AXL, RET, MET, and TIE-2. These receptors are involved in tumor growth and the formation of new blood vessels that supply tumors, so blocking them helps slow or stop cancer progression. For more clinical details, refer to MedlinePlus Drug Information, a trusted resource from the U.S. National Library of Medicine.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Cazanat Cabozantinib 20mg tablets”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Cazanat Cabozantinib 20mg Tablet used for?
Cazanat 20mg Tablet is used to treat medullary thyroid cancer, advanced renal cell carcinoma, and hepatocellular carcinoma.
It should be taken by mouth exactly as prescribed by your doctor, with dose and duration based on your specific condition.
It works by blocking multiple receptor tyrosine kinases involved in tumor growth and blood supply, helping slow or stop cancer progression. For more clinical details, see MedlinePlus Drug Information.
Yes, it is indicated for hepatocellular carcinoma specifically in patients previously treated with sorafenib.
It may take several weeks or months for benefits to become noticeable, so treatment should be continued as prescribed.
Cazanat Cabozantinib 20mg Tablet is manufactured by Natco, supplied as a bottle of 30 tablets.

Related products